Dr Forster is an Associate Professor at University College London (UCL) and Consultant Medical Oncologist at University College London Hospitals NHS Foundation Trust. He specialises in Thoracic and Head and Neck cancers and has a particular interest in drug development, running a broad portfolio of studies from first-in-human to registration Phase III trials. He is Joint Lead for the Clinical Trials Theme of the Cancer Research UK Lung Cancer Centre of Excellence and chairs the NIHR Head & Neck Research Group. He runs a research-based practice, being Principal Investigator or Chief Investigator for over 50 early and late-phase clinical trials since his appointment to UCL in 2009. These include involvement in >10 trials involving immune checkpoint inhibitors, either as single agent or in combination and he has a number of academic immunotherapy studies in development. He collaborates broadly with national and international groups involved in translational research. In addition, he is the UCH clinical lead for chemotherapy services and co-lead for the London Cancer Chemotherapy Expert Reference Group.